Back

Antengene to present Cos-TCE results at SITC 2026

Verifying
  • Antengene will present Cos-TCE preclinical results at the 2026 Society for Immunotherapy of Cancer Annual Meeting.
  • November 6, 2026, is scheduled for the Rapid Oral Abstract Presentation in Phoenix.
  • Antengene has secured 35 investigational new drug approvals in the U.S. and Asia.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.